Login / Signup

Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.

Takashi IshiharaKeiji NogamiSatoshi OchiToshiaki IshidaYoshiyuki KosakaAkihisa SawadaMasami InoueShinya OsoneToshihiko ImamuraHajime HosoiMidori Shima
Published in: Pediatric blood & cancer (2019)
The results demonstrated that hemostatic dynamics appeared to shift to a hypercoagulable state with marked hypofibrinolysis associated with L-Asp therapy, especially in patients ≥10.0 years old following the BFM regimen.
Keyphrases
  • acute lymphoblastic leukemia
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • patient reported outcomes
  • cell therapy
  • bone marrow
  • mesenchymal stem cells
  • acute myeloid leukemia